Philosys Healthcare Signs Supply Contract for COVID-19 Diagnostic Rapid Kit
[Asia Economy Reporter Oh Ju-yeon] Philosis Healthcare announced on the 16th that it has signed a supply contract worth 5 billion KRW for COVID-19 diagnostic rapid kits with Med Care Egypt in Egypt. This amount corresponds to 71.93% of its recent sales revenue.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "Too Much to Handle Alone": Teacher Assaulted for 20 Minutes While Restraining Elementary Student... Ended Only After 5 Staff Arrived
- "Nothing Has Changed": Union Rejects Samsung's Proposal... Further Talks Fail as Strike Proceeds
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
Additionally, through a separate announcement, the company revealed that it signed supply contracts for COVID-19 diagnostic rapid kits worth 3.37 billion KRW with A&B Health Supplies SDN. BHD. in Malaysia, and 3.32 billion KRW with Biogenic S.A in Switzerland and Italy.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
